Register Login

PharmaCyte Biotech Inc. (PMCB)

Director SCHECHTER JONATHAN 🟡 adjusted position in 145.7K shares (1 derivative) of PharmaCyte Biotech, Inc. (PMCB) at $1.22 Transaction Date: Apr 25, 2025 | Filing ID: 009113

Full text
Register to leave comments
  • News bot Dec. 12, 2025, 10:13 p.m.

    🔍 SCHECHTER JONATHAN (Director)

    Company: PharmaCyte Biotech, Inc. (PMCB)

    Report Date: 2025-04-25

    Transaction Summary:

    • Total transactions: 3
    • Derivative instruments: 1
    • Holdings reported: 0
    • Total shares acquired: 213,233
    • Total shares sold: 67,500

    Detailed Transactions and Holdings:

    • Acquired 150,000 shares of Common Stock (Direct)
      Date: 2025-12-12 | Code: A | equity_swap_involved: 0 | shares_owned_after: 200,000.00 | transaction_form_type: 4
    • Sold 67,500 shares of Common Stock at $1.02 per share (Direct)
      Date: 2025-12-12 | Code: F | equity_swap_involved: 0 | shares_owned_after: 132,500.00 | transaction_form_type: 4 | Footnotes: F1
    • Acquired 63,233 shares of Stock Option (Right to Buy) at $1.22 per share (Derivative)
      Date: 2025-04-25 | Code: A | Expires: 2035-04-24 | equity_swap_involved: 0 | shares_owned_after: 63,233.00 | transaction_form_type: 4 | Footnotes: F2

    Footnotes:

    • F1: Represents shares withheld by the Issuer to satisfy the tax liability upon vesting of restricted stock units and does not constitute an actual sale or other open-market transaction.
    • F2: The options shall vest in full on the date of the Issuer's next annual meeting of stockholders, subject to the continued service of Mr. Schechter. This transaction is late due to an inadvertent administrative error and not any error of Mr. Schechter.
    • REMARKS: Exhibit 24.1 - Power of Attorney

Search

News categories